Exelixis
EXEL
#1759
Rank
ยฃ8.84 B
Marketcap
ยฃ32.87
Share price
-0.25%
Change (1 day)
13.66%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company